Moderate riskFDA DrugClass II

Merck Noxafil Powdermix (posaconazole) recalled for potential metal particulates

Merck has recalled specific lots of Noxafil Powdermix, a prescription antifungal medication, because some packets may contain metal particles. This affects 845 kits distributed nationwide. No injuries have been reported.

From the FDA notice · Read the official notice ↗

What to do

  1. Check if you have Noxafil Powdermix lot Z012339, Z010344, Z009908, or Z009909 with expiration date 12-31-2026
  2. Do not use the product if you have one of these lots
  3. Contact your pharmacy or doctor for a replacement or alternative medication
  4. Return the recalled product to your pharmacy

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension, 300 mg, 8 packets per carton, Rx Only, Manufactured for: Merck Sharp & Doohme LLC, Rahway, NJ 07056 USA, Manufactured by: N.V. Organon, 5349 AB Oss, The Netherlands, a subsidiary of Organon & Co., Jersey City, NJ 07302, USA NDC 0085-2224-02.
Sold in
Nationwide
Made for
Adults (0 months and older)

This recall covers 2 products — see all of them.

Details

Units affected
845 kits
Illnesses reported
None reported
Manufactured in
4633 Merck Rd W, N/A, Wilson, NC, United States
Classification
Class II
Recall number
D-0242-2026

In the FDA's words

Description
Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension, 300 mg, 8 packets per carton, Rx Only, Manufactured for: Merck Sharp & Doohme LLC, Rahway, NJ 07056 USA, Manufactured by: N.V. Organon, 5349 AB Oss, The Netherlands, a subsidiary of Organon & Co., Jersey City, NJ 07302, USA NDC 0085-2224-02. Presence of particulate matter: potential presence of metal particulates in the product. Lot#: Z012339, Z010344, Z009908, Z009909, Exp Date 12-31-2026 Distribution: Nationwide in the USA Affected quantity: 845 kits
Hazard
Presence of particulate matter: potential presence of metal particulates in the product.

2 products in this recall

Merck Emend and Noxafil Powdermix recalled for metal particulates

Merck is recalling two prescription medicines, Emend (aprepitant) for oral suspension 125 mg single-dose kits and Noxafil Powdermix (posaconazole) 300 mg packets, because they may contain metal particles. The recall covers 3 Emend kits and 845 Noxafil Powdermix kits, distributed nationwide. No injuries have been reported.

The agency lists each product separately. Check every one you might have.

Related topics

MetalParticulateDrugsSold nationwideMore from FDA Drug